Cargando…
Drug repurposing and human parasitic protozoan diseases
Parasitic diseases have an enormous health, social and economic impact and are a particular problem in tropical regions of the world. Diseases caused by protozoa and helminths, such as malaria and schistosomiasis, are the cause of most parasite related morbidity and mortality, with an estimated 1.1 ...
Autores principales: | Andrews, Katherine T., Fisher, Gillian, Skinner-Adams, Tina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095053/ https://www.ncbi.nlm.nih.gov/pubmed/25057459 http://dx.doi.org/10.1016/j.ijpddr.2014.02.002 |
Ejemplares similares
-
Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases
por: Martínez-Flórez, Alba, et al.
Publicado: (2020) -
Drug resistance in protozoan parasites
por: de Koning, Harry P.
Publicado: (2017) -
Drug repurposing strategies of relevance for Parkinson’s disease
por: Fletcher, Edward J. R., et al.
Publicado: (2021) -
Repurposing approved drugs for cancer therapy
por: Schein, Catherine H
Publicado: (2021) -
Repurposing drugs for the treatment and control of helminth infections
por: Panic, Gordana, et al.
Publicado: (2014)